Q4 2023 · 13F-HR
Carlyle Group Inc. (CG, CGABL)holdings as filed
Filed 2024-02-02 · accession 0000898432-24-000085
$2.08B
Reported value
25
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 219798105 | QDEL | Quidelortho Corp | $918.3M | 44.2% | 12,460,183 | Common | SHARED |
| 98980F104 | GTM | ZoomInfo Technologies Inc | $651.7M | 31.3% | 35,244,474 | Common | SHARED |
| 834203309 | SLNO | Soleno Therapeutics Inc | $115.0M | 5.53% | 2,857,804 | Common | SHARED |
| G9440D103 | — | Vitru Ltd | $98.4M | 4.73% | 6,246,471 | Common | SHARED |
| 374275105 | GETY | Getty Images Holdings Inc | $49.3M | 2.37% | 9,394,319 | Common | SHARED |
| 925050106 | VRNA | Verona Pharma Plc | $48.8M | 2.35% | 2,457,500 | Common | SHARED |
| 36165L108 | GDS | GDS Hldgs Ltd | $37.1M | 1.79% | 4,072,624 | Common | SHARED |
| 71722W107 | PHAT | Phathom Pharmaceuticals Inc | $31.9M | 1.54% | 3,496,808 | Common | SHARED |
| 43157M102 | — | Hillevax Inc | $29.5M | 1.42% | 1,838,486 | Common | SHARED |
| 92337R101 | VERA | Vera Therapeutics Inc | $22.1M | 1.06% | 1,438,155 | Common | SHARED |
| 78413P101 | SMHI | Seacor Marine Hldgs Inc | $16.5M | 0.80% | 1,314,164 | Common | SHARED |
| 46187W107 | INVH | Invitation Homes Inc | $16.3M | 0.78% | 477,500 | Common | SHARED |
| 229663109 | CUBE | CubeSmart | $10.2M | 0.49% | 220,500 | Common | SHARED |
| 85209E109 | — | Spruce Biosciences Inc | $8.4M | 0.40% | 2,896,518 | Common | SHARED |
| 471871103 | — | Jasper Therapeutics Inc | $6.7M | 0.32% | 8,761,891 | Common | SHARED |
| 75974E103 | — | Reneo Pharmaceuticals Inc | $4.3M | 0.21% | 2,698,957 | Common | SHARED |
| 20460L104 | SPWR | Complete Solaria Inc | $4.3M | 0.20% | 2,745,879 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio Inc | $4.0M | 0.19% | 2,115,385 | Common | SHARED |
| 83193E102 | EM | Smart Sh Global Ltd | $2.4M | 0.12% | 4,810,209 | Common | SHARED |
| 28202V108 | — | Effector Therapeutics Inc | $2.2M | 0.11% | 4,822,114 | Common | SHARED |
| 67022C106 | — | Nucana Plc | $967,000 | 0.05% | 3,333,333 | Common | SHARED |
| 68276W400 | — | Meta Data Limited | $306,006 | 0.01% | 314,400 | Common | SHARED |
| 00773J202 | SYRE | Spyre Therapeutics Inc | $203,944 | 0.01% | 9,620 | Common | SHARED |
| 30205M200 | XCUREUR | Exicure Inc | $163,405 | 0.01% | 281,636 | Common | SHARED |
| 608550208 | MTEMEUR | Molecular Templates Inc | $49,332 | 0.00% | 13,333 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.